Louis Archambault
Chercheur universitaire
Axe Oncologie
Physique médicale
Instrumentation optique
Radiologie, médecine nucléaire et imagerie médicale
Modèles informatiques
Calcul numérique
Publications
Voir tout-
article Poher A, Michaud G, Archambault L, Beaulieu L
Polarized Cherenkov light imaging dosimetry: the impact of source to detector distance
Phys Med Biol 2026.
-
article Lessard B, LeChasseur Y, Lambert-Girard S, Therriault-Proulx F, Beaulieu L, Archambault L
Development and characterization of the Hydra: a novel multi-headed, single optical channel scintillation detector
Phys Med Biol 70 (15), 2025.
-
article Bernelin T, Muir B, Renaud J, Zerouali K, Guillet D, Archambault L, Lalonde A
Characterization of a shielded beam current transformer for ultra-high dose rate (FLASH) electron beam monitoring and dose reporting
Med Phys 52 (7), 2025.
Projets
- NSERC CREATE in Responsible Health and Healthcare Data Science, du 2019-09-01 au 2026-08-31
- Engineering bioactive dressings from mesenchymal cells to enhance healing of irradiated skin wounds, du 2022-04-01 au 2027-03-31
- Propulsion d’une plateforme de dosimétrie à scintillation de pointe vers de nouvelles applications à fort potentiel innovant et commercial, du 2022-06-27 au 2026-12-31
- Expanding the boundaries of scintillation dosimetry with data science, signal processing and innovative design, du 2024-04-01 au 2029-03-31
- Enhancing the PARADIM platform to bridge the gap between data and AI in medical imaging, du 2024-09-01 au 2027-08-31
- Bringing three-dimensional dosimetry in the clinic for advanced quality control in radiation therapy, du 2025-01-13 au 2028-06-30
- Dosimétrie par polarimétrie du rayonnement Cherenkov en radiothérapie, du 2025-07-01 au 2027-07-01
- The advent of intelligent real-time dosimetry to optimize image-guided radiotherapy and ensure treatment safety, du 2025-10-01 au 2026-12-31
- New tools and method for monitoring ionizing radiation delivery in medical physics, du 2018-04-01 au 2024-03-31
- Validation clinique de l'Hyperscint MD, du 2023-10-18 au 2024-10-17
- Scale-up and validation of personalized outcome prediction model for newly diagnosed prostate cancer patients by integrating clinicopathological data and multi-task artificial , du 2024-06-17 au 2025-06-16
- 2SHARP:Two Fractions Study of Hypofractionated Ablative Radiotherapy for Prostate Cancer. , du 2024-06-19 au 2025-03-31